Morgan Stanley's Susan Huang: How M&A Will Finish in 2016

The video discusses market trends from 2015 to 2016, highlighting a slowdown in big deals. It explores the healthcare sector, focusing on pharma trends like oncology and rare diseases. The impact of Brexit on cross-border M&A is analyzed, with emphasis on US and European markets. The video concludes with a discussion on women in leadership roles in finance, emphasizing diversity and mentorship.

What impact has Brexit had on cross-border M&A deals?

How does the speaker feel about the representation of women in finance and M&A?

What has been the speaker's experience in the finance industry over the years?